These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3396610)

  • 21. The plasma protein binding of metoclopramide in health and renal disease.
    Webb D; Buss DC; Fifield R; Bateman DN; Routledge PA
    Br J Clin Pharmacol; 1986 Mar; 21(3):334-6. PubMed ID: 3964535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lidocaine protein binding in preeclampsia.
    Bottorff MB; Pieper JA; Boucher BA; Hoon TJ; Ramanathan J; Sibai BM
    Eur J Clin Pharmacol; 1987; 31(6):719-22. PubMed ID: 3556378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity.
    Mazoit JX; Cao LS; Samii K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):109-15. PubMed ID: 8558418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gallopamil binding to human serum proteins.
    Rutledge DR; Pieper JA
    Eur J Clin Pharmacol; 1987; 33(4):375-80. PubMed ID: 3443143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of plasma proteins, albumin and alpha 1-acid glycoprotein, to pharmacokinetics of a multi-targeted receptor tyrosine kinase inhibitor, sunitinib, in analbuminemic rats.
    Toyama Y; Ueyama J; Nomura H; Tsukiyama I; Saito H; Hisada T; Matsuura K; Hasegawa T
    Anticancer Res; 2014 May; 34(5):2283-9. PubMed ID: 24778032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein binding of cocaine in human serum.
    Edwards DJ; Bowles SK
    Pharm Res; 1988 Jul; 5(7):440-2. PubMed ID: 3247314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free and total plasma levels of lopinavir during pregnancy, at delivery and postpartum: implications for dosage adjustments in pregnant women.
    Fayet-Mello A; Buclin T; Guignard N; Cruchon S; Cavassini M; Grawe C; Gremlich E; Popp KA; Schmid F; Eap CB; Telenti A; Biollaz J; Decosterd LA; Martinez de Tejada B; ;
    Antivir Ther; 2013; 18(2):171-82. PubMed ID: 22914504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential effect of cancer on the serum protein binding to mianserin and imipramine.
    Torres I; Suárez E; Rodríguez-Sasiain JM; Aguirre C; Calvo R
    Eur J Drug Metab Pharmacokinet; 1995; 20(2):107-11. PubMed ID: 8582434
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of penbutolol on lidocaine kinetics.
    Ochs HR; Skanderra D; Abernethy DR; Greenblatt DJ
    Arzneimittelforschung; 1983; 33(12):1680-1. PubMed ID: 6686773
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant.
    Wood M; Wood AJ
    Clin Pharmacol Ther; 1981 Apr; 29(4):522-6. PubMed ID: 7471620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of penbutolol and its hydroxylated metabolite in biological fluids by reversed-phase high-performance liquid chromatography.
    Bernard N; Cuisinaud G; Sassard J
    J Chromatogr; 1982 Mar; 228():355-61. PubMed ID: 7076761
    [No Abstract]   [Full Text] [Related]  

  • 33. Single and divided doses of penbutolol.
    Müller FO; Hundt HK; Bromley PA; Torres J; Vanderbeke O
    Clin Pharmacol Ther; 1979 May; 25(5 Pt 1):528-35. PubMed ID: 436357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma protein binding of etidocaine during pregnancy and labour.
    Morgan DJ; Koay BB; Paull JD
    Eur J Clin Pharmacol; 1982; 22(5):451-7. PubMed ID: 7117359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of oral penbutolol on renal haemodynamics of hypertensive patients with renal insufficiency.
    Bailey RR; Carlson RV; Walker RJ; Swainson CP
    N Z Med J; 1985 Aug; 98(785):683-5. PubMed ID: 3863029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma protein binding of disopyramide in pregnant and postpartum women, and in neonates and their mothers.
    Echizen H; Nakura M; Saotome T; Minoura S; Ishizaki T
    Br J Clin Pharmacol; 1990 Apr; 29(4):423-30. PubMed ID: 2183867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein binding predictions in infants.
    McNamara PJ; Alcorn J
    AAPS PharmSci; 2002; 4(1):E4. PubMed ID: 12049488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of bornaprolol to human serum proteins and blood cells.
    Shastri RA; Barre J; Houin G; Hamberger C; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1986 Jul; 24(7):351-6. PubMed ID: 3733286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.